There was an overall increase in the expression of Aβ42, P-T181-tau, and metalloproteinase-9 (MMP-9) in AD patients compared to controls, whereas no difference was detected in the P-S396-tau and IL-6 levels in plasma NDEs. This evidence concerns the gene MAPT and Alzheimer disease.